Navigation Links
Van in Medical Technology

Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection

CE IVD Menu Expanded to Eight On-Demand Tests for Use on the GeneXpert(R) System SUNNYVALE, Calif., Oct. 7 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced the release of Xpert(TM) vanA/vanB as a European CE IVD Mark product under the European Dir...

Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

...ous fracture and subsequent fracture risk. Bone 35:375. (13) Clinical subsequent fractures cluster in time after first fractures. T A C M van Geel, et al, Annals of the Rheumatic Diseases 2009;68:99-102. (14) http://orthoinfo.aaos.org/topic.cfm?topic=A00121 , accessed ...

Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th

... III EXTEND PIX 301 clinical trial of pixantrone (the "PIX 301 EXTEND trial") is being presented at the Pan Pacific Lymphoma conference by Dr. Richard van der Jagt of the Ottawa General Hospital. Pixantrone PIX 301 EXTEND Trial Follow-up Data and Subgroup Analyses Initial follow-up data in t...

AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria

...marketing approval. "We are proud to have received this Orphan Drug Designation for the treatment of acute intermittent porphyria," said Sander van Deventer, Chief Executive Officer of AMT. "This designation is an important step in the development of a treatment for this seriously debilitating and...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease

...e year were also lower with PCI. Analysis of the data was presented by Ben van Hout, Ph.D., of the University of Utrecht, The Netherlands, at the annual E...the first year following treatment, as compared to CABG patients," said Dr. van Hout. "This analysis will be especially helpful to physicians and hospital...

Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery

...ncet.com/pdfs/journals/lancet/PIIS0140673609605006.pdf?i d=aeaa5a245ca1fddb:3c6bded9:1201d7429fe:-15be1237448848073. Last accessed 14.04.09 3. van den Abbeele A., Benjamin R., Blanke C, et al. Clinical Management of GIST. Recurrence patterns and prognostic factors for survival. Highlights From th...

Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases

...ls and shows activity towards intraphagocytic linezolid-sensitive and linezolid-resistant S. aureus ; S. Lemaire, K. Kosowska-Shick, P. Appelbaum, F. van Bambeke, P. Tulkens P 1090 : The safety of single ascending oral doses of TR-701, a novel oxazolidinone prodrug antibiotic; P. Bien, P. Proko...

Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis

... specimens." John Ward, et al. (4) AUA poster #1814, "Feasibility of the PCA3 urine test in a community- based screening setting." Adrie van Bokhoven, et al. (5) UROLOGY(R) (69:532-535, 2007). Contact: Michael Watts Vice president, investor relations and corporate ...

DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium

...Anemia and Iron Status in Hemodialysis Patients Authors: David B. van Wyck(1), Harry Alcorn(1), Resmi Gupta(2) (1)DaVita, Inc., El Segu...: Jessica E Miller(1), Elani Streja(1), Csaba P Kovesdy(2), David van Wyck(3), Allen R. Nissenson(3), and Kamyar Kalantar- Zadeh(1) ...

ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009

...he quarter ended September 30, 2008, and other reports filed by us with the Securities and Exchange Commission. Contact: Company Renaat van den Hooff President & CEO Terry K. Wallberg Vice President & CFO (214) 905-5145 ...

Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development

...ent program of Nobilon," said Gelmer Leibbrandt, general manager of Nobilon. "This is an important milestone in the young history of our company." Han van den Bosch, Director R&D, stated: "We are encouraged by the positive results obtained in the pre-clinical development of our candidate vaccine so f...

Can Exercising Your Brain Prevent Memory Loss?

...m these findings with additional research." The study was supported by the National Institutes of Health, Robert H. and Clarice Smith and Abigail van Buren Alzheimer's Disease Research Program and the Robert Wood Johnson Foundation. Additional audio and video resources, including excerpts from ...

Infant Blood May Provide Insights into Diseases Present at Birth

... GRAND RAPIDS, Mich., Dec. 15 /PRNewswire/ -- van Andel Institute (VAI) researchers are the first to...rmed consent. Established by Jay and Betty van Andel in 1996, van Andel Institute is an independent research organiz...

Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer

...ecular cancer diagnostics, today announced MammaPrint(R)'s ability to predict response to neoadjuvant chemotherapy in breast cancer. Dr. Laura van 't Veer, from the Netherlands Cancer Institute, presented the data at the 2008 San Antonio Breast Cancer Symposium (SABCS) during the session Molecula...

Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium

...apeutic Decisions: "RNA". Presenter: Laura van 't Veer, PhD, Netherlands Cancer Institute. F...l in breast cancer patients." Presenter: Laura van 't Veer, PhD, Netherlands Cancer Institute. F...ical Oncology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands ...

Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults

...ny does not undertake to update any forward-looking statements as a result of new information or future events or developments.) Contacts: Pam van Houten Mobile: (908) 295-7367 ...

ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver

...cal data to apply for a CE mark which will enable Altrazeal(TM) Silver to be marketed in Europe and Canada. Commenting on the clinical study, Renaat van Den Hooff, Executive Vice President of Operations stated, "Silver containing dressings are used extensively in the skin graft donor site indication to...

VAI Finding Could Lead to New Drugs for Anxiety, Depression

...rchers in the Laboratory of Structural Sciences at van Andel Institute (VAI) have determined how the horm...ily going forward." Established by Jay and Betty van Andel in 1996, van Andel Institute is an independent research organiz...

VAI Findings Could Aid Diagnosis and Treatment of Several Types of Kidney Cancer

... van Andel Institute researchers are first to associate...ma GRAND RAPIDS, Mich., Sept. 12 /PRNewswire/ -- van Andel Institute (VAI) researchers have identified ... disease each year. Established by Jay and Betty van Andel in 1996,...

Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008

... of innovative HIV/AIDS drugs and anti-infectives for diseases of high unmet medical need. Media Contacts: Karen Manson - 32-479-89-47-99 Pam van Houten - 908-295-7367 Investor Relations Contacts: Lesley Fishman - 732-542-3922 Louise Mehrota - 732-524-6491 ...

Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets

...he Mayo Clinic study of aging: Incidence of mild cognitive impairment." (Funders: National Institute on Aging; Robert H. and Clarice Smith and Abigail van Buren Alzheimer's Disease Research Program of the Mayo Clinic) -- Donald E. Schmechel. "A phase 2, double-blind, placebo-controlled study to evaluat...

Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules

...from Germany, France and the UK highlight the impact of the vaccine in countries where it is part of the national immunization schedule," says Dr Mark van der Linden, Head of the National Reference Center for Streptococci at the Institute of Medical Microbiology, RWTH-Aachen, Germany. The World Health ...

Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent

...rst use study of voclosporin on an implantable medical device will enroll 100 patients, and will be conducted at seven hospitals in Belgium with Glenn van Langenhove, MD, PhD of Middelheim Hospital, Antwerp, as the study's Principal Investigator. The primary endpoint of the trial is to evaluate the safet...

Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)

...eferences and Glossary 1 Simon, Richard, "Optimal Two-Stage Designs for Phase II Clinical Trials," Controlled Clinical Trials 10:1-10 (1989) 2 E. van Cutsem, I. Lang, G. D'haens, V. Moiseyenko, J. Zaluski, G. Folprecht, S. Tejpar, O. Kisker, C. Stroh, P. Rougier, "KRAS status and efficacy in t...

Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R)

...nts are diagnosed with advanced disease. "For patients with advanced pancreatic cancer, the treatment options are limited," commented Professor Eric van Cutsem, Professor of Medicine, Gastrointestinal Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium. "The interesting results show the ne...

AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication

...0-day mortality from peptic ulcer bleeding and perforation: a Danish population-based cohort study. Diabetes Care 2006;29(4):805-10. (8) van Leerdam ME et al Acute upper GI bleeding: Did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding bet...

Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer

...hird study (abstract 11048, (4)), presented by Dr. van Laere from Antwerp University, Belgium, validates ...tract.asco.org/AbstView_55_33741.html (4) S. J. van Laere, G. G. van den Eynden, I....

St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity

... and Richard Smeyne (St. Jude); Harvir Singh, Andrzej Chruscinski and Paul Utz (Stanford University School of Medicine, Stanford, Calif.); and Nicolai van Oers (The University of Texas Southwestern Medical Center, Dallas). This work was supported by the National Institutes of Health, a Cancer Center ...

Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women

...differences by race, according to Karmanos Principal Investigator Alison L. van Dyke, MD/PhD Candidate, Class of 2011. Genetic variation was evaluated by l...populations to confirm these findings," said Dr. Schwartz. According to van Dyke, this type of information might be used to better predict who to scree...

Study Finds Repeated Episodes of Stent Thrombosis Common

...rican College of Cardiology (ACC). Jochem Wouter van Werkum, MD, a cardiologist at St Antonius Hospital...e usual risk of a repeat episode (p=0.0127). Dr. van Werkum and his colleagues concluded that additiona...he first stent thrombosis should be avoided. Dr. van Werkum will present the results of the "Dutch Sten...

ACR Supports American Cancer Society Inclusion of CT Colonography (Virtual Colonoscopy) as Recommended Screening Tool for Colorectal Cancer in New Screening Guidelines

...of the disease for more patients, increasing the chance of successful treatment, and potentially reduce colorectal cancer deaths nationwide," said Arl van Moore Jr., M.D., FACR, chair of the ACR Board of Chancellors. Results of the National CT Colonography Trial coordinated by the American College of...

Test for Life Campaign Screens Record Number of DC Residents for HIV/AIDS

... Test for Life: Maura O'Connor (202) 572-6252 Washington Wizards Communications Department: Zack Bolno, Brian Sereno, Daren Jenkins or Whitney van Wyk at 202-661-5112 Verizon Washington, DC: Christy Reap 202-392-1021 ...

Mayo Clinic Finds Capsule Endoscopy Can Detect Intestinal Damage Caused by Celiac Disease

...intestinal damage both prior to and following treatment." Other members of the Mayo Clinic research team included Alberto Rubio Tapia, M.D., Carol van Dyke, Deanna Brogan, Mary Knipschield, Brian Lahr, Ashwin Rumalla, Alan Zinsmeister, Ph.D., and Christopher Gostout, M.D. Each year, physicians at...

Bionomics Achieves US$1 Million Milestone Payment from Genmab

...leased to reach the next level of development with these targets and look forward to continuing the collaboration with Bionomics." Professor Jan G J van de Winkel, PhD, Chief Scientific Officer of Genmab added: "This milestone has been reached following extensive studies by Genmab on the Bionomics targ...

QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Women's Health Issues

...kind software and database system developed at the van Andel Research Institute. This specialized bio-inf...Craig Webb, Ph.D. and Jeremy Miller, Ph.D., of the van Andel Research Institute, a co-founding joint vent...the capabilities of CMM joint venture partners the van Andel Institute and Spectrum Health. "CMM is ple...

New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy

...ot undertake to update any forward-looking statements as a result of new information or future events or developments. Media Contact: Pamela van Houten 908-541-4137 (office) 908-295-7367 (mobile) Investor Relations: Lesley Fishman ...

Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration

...novative virology therapeutics that help healthcare professionals address serious unmet needs in people living with HIV. Media Contact: Pamela van Houten Office: 908-541-4137 Mobile: 908-295-7367 Investor Contact: Louise Mehrotra (732) 524-6491 ...

WaveSense Blood Glucose Meter One of Few Brands to Pass Rigorous TNO Tests

...Blood Glucose also carries the CE Marking. "Receiving the TNO approval is a testament to the quality and accuracy of WaveSense products," said Dr. E. van Ballegooie, one of the leading physicians in the Belgium/Netherlands/Luxembourg region. "Roche and Abbott are the other major brands to receive the TN...

ACRIN Study Endorses Virtual Colonoscopy - Validation for Colon CAD Software Maker Medicsight plc

...ned readers, CT colonography is a viable and robust screening tool for colorectal cancer." For further information: MGT Capital Investments Alex van Klaveren Tel: +1 646 257 2674 http://www.mgtci.com Media enquiries: KCSA Worldwide Todd Fromer / Garth Russell 212-896-1215 / 212-896-1...

New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy

...s a trademark owned by Gilead Sciences, Inc. 2. Kaletra(R) (lopinavir/ritonavir) is a trademark owned by Abbott Laboratories Contacts: Pam van Houten Office: (908) 541-4137 ...
Other Tags
(Date:12/19/2014)...   LaunchKey , the first decentralized mobile authentication ... of Things era, today announced the close of $3 ... led by Metamorphic Ventures with participation from ENIAC Ventures, ... others.  LaunchKey has raised $4 million to date, and ... and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... -- Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ... with the clinical data to back it up," said ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ...  report to their offering. One ... in technology. With continuous advances in technology, it ... latest standard that meets the needs and expectations ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/21/2014)... SCI explores disability in sports this ... for disabled athletes with Aaron Scheidies , legally ... called juvenile macular degeneration, where he loses his central ... athletic ambitions to his vision and how he has ... the way for other blind and visually impaired athletes. ...
(Date:12/21/2014)... Virginia (PRWEB) December 21, 2014 Concept Plus, ... and engineering firm headquartered in Fairfax, VA., today announced ... of its Fast 50 list, which ranks the fastest growing ... rate from 2009 to 2013. , This is the first ... and it ranked # 20 with a 95.92% compound annual ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 An improving ... sector have benefited the Massage Services industry ... characteristics of industry products, the anticipated 1.0% annualized increase ... has provided consumers with the means to afford additional ... received a massage in a given year has declined ...
(Date:12/20/2014)... 2014 Recently, VogueQueen.com, a leading wedding ... Big Sale Online for 2015. Great discounts are ... and old consumers can get a discount, up to ... company’s website before January 30, 2015. , VogueQueen.com has ... launched a prom dress promotion. Many customers worldwide like ...
(Date:12/20/2014)... 20, 2014 The aftermath of the November ... stir, not only in Hollywood, but worldwide. As ... the ripples of that attack are starting a finger-pointing game ... risk. But they are not the only ones affected, ... in for some embarrassing times ahead, agents and lawyers could ...
Breaking Medicine News(10 mins):Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5
Other Contents